About: BioGaia     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:SocialGroup107950920, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FBioGaia&invfp=IFP_OFF&sas=SAME_AS_OFF

BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis (DSM 17938), one of the human L. reuteri strain and oral health products containing L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30

AttributesValues
rdf:type
rdfs:label
  • BioGaia (en)
  • Biogaia (sv)
rdfs:comment
  • BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis (DSM 17938), one of the human L. reuteri strain and oral health products containing L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 (en)
  • Biogaia AB är ett svenskt bioteknikföretag som utvecklar och säljer probiotiska produkter. Biogaia har utvecklats från forskningsrön om mjölksyrebakterien Limosilactobacillus reuteri och substansen reuterin, som utfördes av Walter Dobrogosz och Sven Lindgren på 1980-talet. Dessa bildade då det amerikanska företaget Probiologics International 1987. Detta – och dess patent – köptes av det 1990 bildade svenska företaget Biogaia. Företagets produkter baseras på olika stammar av Limosilactobacillus reuteri , som Lm. reuteri protectis för mag- och tarmhälsa och Lm. reuteri prodentis för munhälsa. (sv)
foaf:name
  • BioGaia (en)
foaf:homepage
name
  • BioGaia (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/BioGaia®_logo_PMS_296.png
location
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
thumbnail
area served
  • Worldwide (en)
foundation
homepage
industry
key people
  • (en)
  • Peter Rothschild (en)
location
  • Stockholm, Sweden (en)
logo
products
has abstract
  • BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis (DSM 17938), one of the human L. reuteri strain and oral health products containing L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. (en)
  • Biogaia AB är ett svenskt bioteknikföretag som utvecklar och säljer probiotiska produkter. Biogaia har utvecklats från forskningsrön om mjölksyrebakterien Limosilactobacillus reuteri och substansen reuterin, som utfördes av Walter Dobrogosz och Sven Lindgren på 1980-talet. Dessa bildade då det amerikanska företaget Probiologics International 1987. Detta – och dess patent – köptes av det 1990 bildade svenska företaget Biogaia. Företagets produkter baseras på olika stammar av Limosilactobacillus reuteri , som Lm. reuteri protectis för mag- och tarmhälsa och Lm. reuteri prodentis för munhälsa. Läkemedelsforskningsbolaget Infant Bacterial Therapeutics avknoppades 2016 från Biogaia. Biogaias B-aktie listades på Stockholmsbörsens O-lista 1998, och finns idag på Mid Cap-listan. (sv)
gold:hypernym
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 50 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software